 | Related Articles |
Efficacy and safety of dinaciclib vs ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemia.
Blood. 2017 03 30;129(13):1876-1878
Authors: Ghia P, Scarfò L, Perez S, Pathiraja K, Derosier M, Small K, McCrary Sisk C, Patton N
PMID: 28126927 [PubMed - indexed for MEDLINE]
http://ift.tt/2kEoKRe
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου